GGrantIndex
← Search

Cancer Risk and Disparities

$93,013P30FY2015CANIH

Dana-Farber Cancer Inst, Boston MA

Investigators

Linked publications, trials & patents

Paper 39713466Paper 39666914Paper 39605676Paper 39593217Paper 39536083Paper 39532885Paper 39484503Paper 39389170Paper 39322760Paper 39168126Paper 39160372Paper 39107288Paper 39042477Paper 39025073Paper 39024561Paper 38996877Paper 38992034Paper 38979326Paper 38979245Paper 38942046Paper 38924531Paper 38889153Paper 38861327Paper 38815709Trial NCT03029325Trial NCT02627430Trial NCT02142803Trial NCT02097225Trial NCT02079740Trial NCT01940809Trial NCT01835184Trial NCT01822509Trial NCT01575522Trial NCT01434316Trial NCT01307631Trial NCT01283035Trial NCT01116648Trial NCT01026324Trial NCT00956163Trial NCT00888134Trial NCT00662506Trial NCT00622401Trial NCT00458978Trial NCT00458549Trial NCT00429910Trial NCT00400946Trial NCT00376480Trial NCT00357500Trial NCT00301093Trial NCT00126672Trial NCT00101075Trial NCT00098865Trial NCT00098514Trial NCT00096291Trial NCT00095927Trial NCT00095901Trial NCT00095875Trial NCT00095836Trial NCT00090857Trial NCT00084838Trial NCT00083031Trial NCT00079326Trial NCT00072436Trial NCT00069940Trial NCT00053976Trial NCT00052611Trial NCT00047294Trial NCT00047281Trial NCT00020670Trial NCT00020605Trial NCT00007917Trial NCT00006107Trial NCT00005988Trial NCT00005096Trial NCT00004180Trial NCT00004163Trial NCT00004070Trial NCT00003761Trial NCT00003744Trial NCT00003657Trial NCT00003200Trial NCT00003058Trial NCT00003045Patent 9512485Patent 7786269Patent 7396678Patent 7229755Patent 7048929Patent 6908617Patent 6479284Patent 6479281Patent 5861424Patent 5670530Patent 5618831Patent 5502214Patent 5360803Patent 4625014Patent 4618492Patent 4542225Patent 4035566

Abstract

PROJECT SUMMARY (See instructions): The mission of the Cancer Risk and Disparities Program is to support research that will lead to a reduction of cancer risk and disparities across society. To achieve this goal, the Program has the following four specific aims: 1. Understand the individual, psychosocial, organizational and community-level factors that determine differences in cancer risk across the life course and population groups. 2. Develop, test and evaluate interventions to reduce cancer risk across the life course and population groups. 3. Advance the science of communication and knowledge translation to promote dissemination of evidence-based interventions to reduce cancer risk. 4. Examine causes of disparities in cancer risk and incidence and Identify interventions to redress these disparities. The Program was initially funded in 2000 when the Dana-Farber/Harvard Cancer Center was established as a consortium Center, and received a merit score of excellent to outstanding at the time of the last renewal in 2005. The Program Is led by L. Frazier(DFCI). There are two Co-Leaders: K. Viswanath (DFCI) and D. Williams(HSPH). During the current project period, the goals of the Program were substantially revised to include new research foci including: 1) the individual and societal factors that predispose to cancer risk, 2) the science of dissemination and 3) an explicit focus on cancer disparities, all of which represent expanded and vibrant strengths within the Program. The expertise of the 49 members spans epidemiology, molecular epidemiology, behavioral science, communication science, intervention science, health policy and dissemination. In 2009, the Program received $19.7 million in cancer-relevant funding (total costs), which included over $11.9 million in NCI funding and $6.5 million in other federal, peer-reviewed funding. Attesting to the productivity and interactivity of the Program are the 903 publications authored by members of the Program during the project period (2006 to 2010), of which 15.5% were Intra-programmatic ,18% were inter-programmatic and 16% were inter-institutional collaborations.

View original record on NIH RePORTER →